Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450
Authors:
- C. Nicholas HodgeCHC. Nicholas Hodge
- Paul E. AldrichPAPaul E. Aldrich
- Lee T. BachelerLBLee T. Bacheler
- Chong-Hwan ChangCCChong-Hwan Chang
- Charles J. EyermannCECharles J. Eyermann
- Sena GarberSGSena Garber
- Mary GrubbMGMary Grubb
- David A. JacksonDJDavid A. Jackson
- Prabharkar K. JadhavPJPrabharkar K. Jadhav
- Bruce KorantBKBruce Korant
- Patrick Y.S. LamPLPatrick Y.S. Lam
- Michael B. MaurinMMMichael B. Maurin
- 1 April 1996
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 3 (4) , 301-314
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Progress in anti-HIV structure-based drug designTrends in Biotechnology, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Crystal structure of HIV-1 protease in complex with VX-478, a potent and orally bioavailable inhibitor of the enzymeJournal of the American Chemical Society, 1995
- THE RETROVIRAL ENZYMESAnnual Review of Biochemistry, 1994
- A C 2 Symmetry-Based HIV Protease Inhibitor, A77003, Irreversibly Inhibits Infectivity of HIV-1 In VitroAIDS Research and Human Retroviruses, 1994
- Crystal structures of HIV-1 protease-inhibitor complexesPerspectives in Drug Discovery and Design, 1993
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- Recent advances in the design of HIV proteinase inhibitorsAntiviral Research, 1992
- The HIV-1 Protease as a Therapeutic Target for AIDSAIDS Research and Human Retroviruses, 1992
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990